[go: up one dir, main page]

FI900175A0 - Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja - Google Patents

Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja

Info

Publication number
FI900175A0
FI900175A0 FI900175A FI900175A FI900175A0 FI 900175 A0 FI900175 A0 FI 900175A0 FI 900175 A FI900175 A FI 900175A FI 900175 A FI900175 A FI 900175A FI 900175 A0 FI900175 A0 FI 900175A0
Authority
FI
Finland
Prior art keywords
method prepares
pharmaceutically valuable
benzazepines
fused benzazepines
prepares pharmaceutically
Prior art date
Application number
FI900175A
Other languages
English (en)
Swedish (sv)
Other versions
FI93212B (fi
FI93212C (fi
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Us Gold
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI900175A0 publication Critical patent/FI900175A0/fi
Publication of FI93212B publication Critical patent/FI93212B/fi
Application granted granted Critical
Publication of FI93212C publication Critical patent/FI93212C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
FI900175A 1987-07-15 1990-01-12 Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja FI93212C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8701636 1987-07-15
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
EP87110253 1987-07-16
EP87110253A EP0299101B1 (en) 1987-07-15 1987-07-16 Fused benzazepines

Publications (3)

Publication Number Publication Date
FI900175A0 true FI900175A0 (fi) 1990-01-12
FI93212B FI93212B (fi) 1994-11-30
FI93212C FI93212C (fi) 1995-03-10

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900175A FI93212C (fi) 1987-07-15 1990-01-12 Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja

Country Status (13)

Country Link
EP (2) EP0363353B1 (fi)
JP (1) JPH0678317B2 (fi)
AT (1) ATE78467T1 (fi)
AU (1) AU617651B2 (fi)
DE (1) DE3780649T2 (fi)
DK (1) DK162889C (fi)
ES (1) ES2043623T3 (fi)
FI (1) FI93212C (fi)
GR (1) GR3006671T3 (fi)
HU (1) HU203537B (fi)
NO (1) NO177264C (fi)
WO (1) WO1989000561A1 (fi)
ZA (1) ZA875183B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168787B1 (pl) * 1989-08-03 1996-04-30 Smithkline Beecham Biolog Sposób wytwarzania czastki kompozytowej PL
JPH0613474B2 (ja) * 1990-02-02 1994-02-23 シェリング・コーポレーション ４，５―シクロアルカノ―３―ベンズアゼピン―７―オール誘導体およびその使用
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
DE60321354D1 (de) * 2002-08-29 2008-07-10 Schering Corp Selektive d1/d5 rezeptorantagonisten zur behandlung von fettleibigkeit und von zns störungen
WO2005035504A2 (en) * 2003-05-22 2005-04-21 Schering Corporation 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
WO1987004430A2 (en) * 1986-01-16 1987-07-30 Schering Corporation Fused benzazepines

Also Published As

Publication number Publication date
AU8037887A (en) 1989-02-13
DE3780649D1 (de) 1992-08-27
HU203537B (en) 1991-08-28
DK9390A (da) 1990-03-12
DK162889C (da) 1992-05-11
FI93212B (fi) 1994-11-30
ZA875183B (en) 1988-04-08
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
ATE78467T1 (de) 1992-08-15
GR3006671T3 (fi) 1993-06-30
NO900186D0 (no) 1990-01-12
JPH0678317B2 (ja) 1994-10-05
EP0299101A1 (en) 1989-01-18
DK162889B (da) 1991-12-23
DE3780649T2 (de) 1992-12-10
NO900186L (no) 1990-01-12
DK9390D0 (da) 1990-01-12
JPH02504629A (ja) 1990-12-27
FI93212C (fi) 1995-03-10
WO1989000561A1 (en) 1989-01-26
EP0363353B1 (en) 1992-07-22
EP0299101B1 (en) 1992-09-23
AU617651B2 (en) 1991-12-05
ES2043623T3 (es) 1994-01-01
EP0363353A1 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
FI965203A7 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
EP0626402A3 (en) Process for the preparation of linear monofunctional and bifunctional telechelic polymers and compositions made therefrom.
CS38989A2 (en) Method of phenoxyacetamidoderivative production
WO1987004430A3 (en) Fused benzazepines
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
BR8806217A (pt) Derivados de 2,2-difluorciclopropiletano,processo para sua preparacao,composicoes praguicidas e aplicacao
NO20013941D0 (no) Polynukleotider med forkortet kjede og fremgangsmate ved fremstillingen derav
TW362096B (en) Novel piperidine derivatives and the process for preparing the same
DE69413410D1 (de) Abschmelzelektrodeverfahren zur herstellung von mikrolegierten produkten
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
DE59604829D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin
FI900175A0 (fi) Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja
FR2714063B1 (fr) Procédé de préparation de collagène à partir de cnidaires, et compositions obtenues utilisables en cosmétique.
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
IL74138A0 (en) Indolophenanthridines,their production and pharmaceutical compositions containing them
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
NO984681D0 (no) Forbedret fremgangsmÕte for fremstilling av enantiomerisk ren azetidin-2-karboksylsyre
KR960701075A (ko) 신규 2'-메틸리덴 뉴클레오티드 화합물, 그의 제조 방법 및 그의 약학적 용도[novel 2'-methylidenenucleotide compound, process for producing the same, and pharmaceutical use thereof]
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE19675009I2 (de) Verfahren zur Herstellung von Hylan und Hylanverbindungen.
DE69840863D1 (de) Verfahren zur Herstellung von 2,6-Diaminopurin-2'deoxyribosid und 2'-Deoxyguanosin

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SCHERING CORPORATION